XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Option Plan and Stock Based Compensation (Tables)
12 Months Ended
Feb. 28, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Options

The following occurred with respect to the Company’s stock options for each of the three years ended February 28, 2022:

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

of Shares

 

 

Exercise

 

 

Contractual

 

 

Value(a)

 

 

 

(exact quantity)

 

 

Price

 

 

Life (in years)

 

 

(in thousands)

 

Outstanding at March 1, 2019

 

 

61,590

 

 

$

15.88

 

 

 

1.8

 

 

$

327

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Terminated

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(61,590

)

 

 

15.88

 

 

 

 

 

 

 

Outstanding at February 29, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
Intrinsic value is measured as the excess fair market value of the Company’s common stock as reported on the NYSE over the applicable exercise price.
Summary of Stock Options Exercised and Tax Benefits Realized from Stock Based Compensation

 

A summary of the stock options exercised and tax benefits realized from stock based compensation is presented below for the three fiscal years ended (in thousands):

 

 

 

Fiscal years ended

 

 

 

2022

 

 

2021

 

 

2020

 

Total grant-date fair value

 

$

 

 

$

 

 

$

201

 

Intrinsic value

 

 

 

 

 

 

 

 

267

 

Summary of Restricted Stock Awards and Restricted Stock Units Activity

The following occurred with respect to the Company’s restricted stock awards for each of the three fiscal years ended February 28, 2022:

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2019

 

155,105

 

 

$

19.03

 

Granted

 

66,669

 

 

 

20.41

 

Terminated

 

(3,920

)

 

 

17.02

 

Vested

 

(73,928

)

 

 

18.90

 

Outstanding at February 29, 2020

 

143,926

 

 

$

19.79

 

Granted

 

59,315

 

 

 

17.09

 

Terminated

 

(10,098

)

 

 

19.00

 

Vested

 

(73,414

)

 

 

19.16

 

Outstanding at March 1, 2021

 

119,729

 

 

$

18.90

 

Granted

 

51,920

 

 

 

20.31

 

Terminated

 

 

 

 

 

Vested

 

(104,485

)

 

 

19.70

 

Outstanding at February 28, 2022

 

67,164

 

 

$

18.73

 

The following occurred with respect to the Company’s restricted stock units for each of the fiscal year ended February 28, 2022:

 

 

Time-based

 

 

Performance-based

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

 

 

Number of

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2021

 

 

 

$

 

 

 

 

 

$

 

Granted

 

44,494

 

 

 

20.38

 

 

 

177,977

 

 

 

23.17

 

Terminated

 

(9,423

)

 

 

20.38

 

 

 

(37,690

)

 

 

23.17

 

Vested

 

 

 

 

 

 

 

 

 

 

 

Outstanding at November 30, 2021

 

35,071

 

 

$

20.38

 

 

 

140,287

 

 

$

23.17